EXEL - EXELIXIS, INC.
41.69
0.950 2.279%
Share volume: 4,159,279
Last Updated: 03-04-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.44%
PREVIOUS CLOSE
CHG
CHG%
$40.74
0.95
0.02%
View ratios
| Fiscal Date | 03-29-2024 | 06-28-2024 | 09-27-2024 | 01-03-2025 | 04-04-2025 | 07-04-2025 | 10-03-2025 | 01-02-2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 04-30-2024 | 08-06-2024 | 10-29-2024 | 02-11-2025 | 05-13-2025 | 07-28-2025 | 11-04-2025 | 02-10-2026 | |
| Total revenue | 425.226 M | 637.178 M | 539.542 M | 566.755 M | 555.447 M | 568.261 M | 597.755 M | 598.663 M | |
| Cost of revenue | 21.256 M | 17.667 M | 17.328 M | 19.965 M | 19.172 M | 19.470 M | 18.574 M | 26.481 M | |
| Gross profit | 403.970 M | 619.511 M | 522.214 M | 546.790 M | 536.275 M | 548.791 M | 579.181 M | 572.182 M | |
| 53.36% | -15.71% | 4.71% | -1.92% | 2.33% | 5.54% | -1.21% | |||
| Operating expenses | 341.673 M | 343.162 M | 334.371 M | 383.330 M | 349.416 M | 335.215 M | 322.825 M | 336.272 M | |
| Selling general and admin | 113.984 M | 132.015 M | 111.801 M | 134.328 M | 137.183 M | 134.859 M | 123.661 M | 123.024 M | |
| Research and development | 227.689 M | 211.147 M | 222.570 M | 249.002 M | 212.233 M | 200.356 M | 199.164 M | 213.248 M | |
| Total expenses | 362.929 M | 343.637 M | 386.139 M | 383.584 M | 349.416 M | 335.215 M | 342.641 M | 336.966 M | |
| -5.32% | 12.37% | -0.66% | -8.91% | -4.06% | 2.22% | -1.66% | |||
| Operating income | 62.297 M | 275.874 M | 136.075 M | 163.206 M | 186.859 M | 213.576 M | 236.540 M | 235.216 M | |
| Ebit | 62.297 M | 275.587 M | 136.046 M | 163.478 M | 186.614 M | 213.626 M | 236.491 M | 235.262 M | |
| Pretax income | 49.267 M | 292.845 M | 154.755 M | 184.773 M | 205.690 M | 230.415 M | 252.413 M | 252.688 M | |
| 494.40% | -47.15% | 19.40% | 11.32% | 12.02% | 9.55% | 0.11% | |||
| Income tax | 11.950 M | 66.729 M | 36.782 M | 44.912 M | 46.074 M | 45.567 M | 58.835 M | 8.160 M | |
| Net income basic | 37.317 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| -100.00% | |||||||||
| Net income | 37.317 M | 226.116 M | 117.973 M | 139.861 M | 159.616 M | 184.848 M | 193.578 M | 244.528 M | |
| 505.93% | -47.83% | 18.55% | 14.12% | 15.81% | 4.72% | 26.32% |